 |
|
Nanoparticles carry cancer-killing drugs into tumor cells
June 15, 2005Increased efficacy, lower drug toxicity in mice
ANN ARBOR, Mich. - University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.
Previous studies in cell cultures have suggested that attaching anticancer drugs to nanoparticles for targeted delivery to tumor cells could increase the therapeutic response. Now, U-M scientists have shown that this nanotechnology-based treatment is effective in living animals.
"This is the first study to demonstrate a nanoparticle-targeted drug actually leaving the bloodstream, being concentrated in cancer cells, and having a biological effect on the animal's tumor," says James R. Baker Jr., M.D., the Ruth Dow Doan Professor of Biologic Nanotechnology at the University of Michigan, who directed the study.
"We're very optimistic that nanotechnology can markedly improve cancer therapy," says Baker, who directs the Michigan Nanotechnology Institute for Medicine and the Biological Sciences. "Targeting drugs directly to cancer cells reduces the amount that gets to normal cells, increases the drug's anti-cancer effect and reduces its toxicity. By improving the therapeutic index of cancer drugs, we hope to turn cancer into a chronic, manageable disease."
Results of the study will be published in the June 15, 2005, issue of Cancer Research.
The drug delivery vehicle used by U-M scientists is a manmade polymer molecule called a dendrimer. Less than five nanometers in diameter, these dendrimers are small enough to slip through tiny openings in cell membranes. One nanometer equals one-billionth of a meter, which means it would take 100,000 nanometers lined up side-by-side to equal the diameter of a human hair.
Dendrimers have a tree-like structure with many branches where scientists can attach a variety of molecules, including drugs. In experiments reported in Cancer Research, U-M scientists attached methotrexate, a powerful anticancer drug, to branches of the dendrimer. On other branches, they attached fluorescent imaging agents and their secret ingredient - a vitamin called folic acid.
Folic acid, or folate, is an important vitamin required for the healthy functioning of all cells. But cancer cells, in particular, seem to need more than average amounts. To soak up as much folate as possible, some cancer cells display more docking sites called folate receptors on their cell membranes. By taking advantage of a cancer cell's appetite for folate, U-M scientists are able to prevent the cells from developing resistance to chemotherapeutic drugs.
"It's like a Trojan horse," Baker explains. "Folate molecules on the nanoparticle bind to receptors on tumor cell membranes and the cell immediately internalizes it, because it thinks it's getting the vitamin it needs. But while it's bringing folate across the cell membrane, the cell also draws in the methotrexate that will poison it."
In conventional chemotherapy, drugs like methotrexate must diffuse across a cell membrane to get inside cancer cells, according to Baker. It's a slow process and requires a high concentration of drug in the extra-cellular fluid, which can damage normal cells and tissues.
When tested in laboratory mice that had received injections of human epithelial cancer cells, the nanoparticle-based therapy using folic acid and methotrexate was 10 times more effective at delaying tumor growth than the drug given alone. Nanoparticle treatment also proved to be far less toxic to mice in the study than the anticancer drug alone.
"In our longest trial, which lasted 99 days, 30 percent to 40 percent of the mice given the nanoparticle with methotrexate survived," says Jolanta Kukowska-Latallo, Ph.D., a U-M research investigator and first author of the study. "All the mice receiving free methotrexate died - either from overgrowth of the tumor or from toxic effects of the drug.
"We saw statistically significant tumor growth reduction in all the mice given targeted nanoparticle therapy, as opposed to mice receiving either free methotrexate or the dendrimer alone," adds Kukowska-Latallo. "Effectively, we achieved a 30-day tumor growth delay. Taking into account the length of a mouse's life, that is significant. One month for a mouse is about three years for a person."
Before they began to study the effects of targeted nanoparticle therapy on cancer, U-M scientists injected dendrimers with fluorescent tags into the bloodstream of laboratory mice to determine where they would be retained in the body. The results showed that the kidneys quickly filtered free nanoparticles from blood and eliminated them in urine. The researchers found no evidence that nanoparticles were able to leave the bloodstream and enter the brain. The nanoparticles did not appear to generate an immune response in mice in the study.
In future research, scientists at the Michigan Nanotechnology Institute will determine the maximum therapeutic dose, in research animals, of targeted nanotherapy with methotrexate, and complete other preliminary studies in preparation for the first human clinical trial, which Baker says is scheduled to begin within two years.
Researchers at the Michigan Nanotechnology Institute also are planning to explore the use of nanotechnology-based therapies using other chemotherapeutic drugs. "There are many cancer drugs that are very effective, but they can't be used now, because they are too toxic," Baker says. "If these drugs can be delivered with a targeted nanoparticle system, we may be able to overcome the toxicity problem and provide a broader range of therapeutic agents for people with cancer.\\\\\\\
University of Michigan Health Systems
"This is the first study to demonstrate a nanoparticle-targeted drug actually leaving the bloodstream, being concentrated in cancer cells, and having a biological effect on the animal's tumor," says James R. Baker Jr., M.D., the Ruth Dow Doan Professor of Biologic Nanotechnology at the University of Michigan, who directed the study.
"We're very optimistic that nanotechnology can markedly improve cancer therapy," says Baker, who directs the Michigan Nanotechnology Institute for Medicine and the Biological Sciences. "Targeting drugs directly to cancer cells reduces the amount that gets to normal cells, increases the drug's anti-cancer effect and reduces its toxicity. By improving the therapeutic index of cancer drugs, we hope to turn cancer into a chronic, manageable disease."
Results of the study will be published in the June 15, 2005, issue of Cancer Research.
The drug delivery vehicle used by U-M scientists is a manmade polymer molecule called a dendrimer. Less than five nanometers in diameter, these dendrimers are small enough to slip through tiny openings in cell membranes. One nanometer equals one-billionth of a meter, which means it would take 100,000 nanometers lined up side-by-side to equal the diameter of a human hair.
Dendrimers have a tree-like structure with many branches where scientists can attach a variety of molecules, including drugs. In experiments reported in Cancer Research, U-M scientists attached methotrexate, a powerful anticancer drug, to branches of the dendrimer. On other branches, they attached fluorescent imaging agents and their secret ingredient - a vitamin called folic acid.
Folic acid, or folate, is an important vitamin required for the healthy functioning of all cells. But cancer cells, in particular, seem to need more than average amounts. To soak up as much folate as possible, some cancer cells display more docking sites called folate receptors on their cell membranes. By taking advantage of a cancer cell's appetite for folate, U-M scientists are able to prevent the cells from developing resistance to chemotherapeutic drugs.
"It's like a Trojan horse," Baker explains. "Folate molecules on the nanoparticle bind to receptors on tumor cell membranes and the cell immediately internalizes it, because it thinks it's getting the vitamin it needs. But while it's bringing folate across the cell membrane, the cell also draws in the methotrexate that will poison it."
In conventional chemotherapy, drugs like methotrexate must diffuse across a cell membrane to get inside cancer cells, according to Baker. It's a slow process and requires a high concentration of drug in the extra-cellular fluid, which can damage normal cells and tissues.
When tested in laboratory mice that had received injections of human epithelial cancer cells, the nanoparticle-based therapy using folic acid and methotrexate was 10 times more effective at delaying tumor growth than the drug given alone. Nanoparticle treatment also proved to be far less toxic to mice in the study than the anticancer drug alone.
"In our longest trial, which lasted 99 days, 30 percent to 40 percent of the mice given the nanoparticle with methotrexate survived," says Jolanta Kukowska-Latallo, Ph.D., a U-M research investigator and first author of the study. "All the mice receiving free methotrexate died - either from overgrowth of the tumor or from toxic effects of the drug.
"We saw statistically significant tumor growth reduction in all the mice given targeted nanoparticle therapy, as opposed to mice receiving either free methotrexate or the dendrimer alone," adds Kukowska-Latallo. "Effectively, we achieved a 30-day tumor growth delay. Taking into account the length of a mouse's life, that is significant. One month for a mouse is about three years for a person."
Before they began to study the effects of targeted nanoparticle therapy on cancer, U-M scientists injected dendrimers with fluorescent tags into the bloodstream of laboratory mice to determine where they would be retained in the body. The results showed that the kidneys quickly filtered free nanoparticles from blood and eliminated them in urine. The researchers found no evidence that nanoparticles were able to leave the bloodstream and enter the brain. The nanoparticles did not appear to generate an immune response in mice in the study.
In future research, scientists at the Michigan Nanotechnology Institute will determine the maximum therapeutic dose, in research animals, of targeted nanotherapy with methotrexate, and complete other preliminary studies in preparation for the first human clinical trial, which Baker says is scheduled to begin within two years.
Researchers at the Michigan Nanotechnology Institute also are planning to explore the use of nanotechnology-based therapies using other chemotherapeutic drugs. "There are many cancer drugs that are very effective, but they can't be used now, because they are too toxic," Baker says. "If these drugs can be delivered with a targeted nanoparticle system, we may be able to overcome the toxicity problem and provide a broader range of therapeutic agents for people with cancer.\\\\\\\
University of Michigan Health Systems
Nanotechnology Current Events and Nanotechnology News RSSNew holographic method could be used for lab-on-a-chip technologies
Researchers at Purdue University have developed a technique that uses a laser and holograms to precisely position numerous tiny particles within seconds, representing a potential new tool to analyze biological samples or create devices using nanoassembly.
Self-powered devices possible, says Texas A&M researcher
Imagine a self-powering cell phone that never needs to be charged because it converts sound waves produced by the user into the energy it needs to keep running. It's not as far-fetched as it may seem thanks to the recent work of Tahir Cagin, a professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University.
Stanford blood scanner detects even faint indicators of cancer
A team led by Stanford researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival.
Study shows direct link between leptin and obesity-related cardiovascular disease
Obese people who don't have high cholesterol or diabetes might think they're healthy - despite the extra pounds.
Researchers discover method for mass production of nanomaterial graphene
Graphene is a perfect example of the wonders of nanotechnology, in which common substances are scaled down to an atomic level to uncover new and exciting possibilities.
New small-scale generator produces alternating current by stretching zinc oxide wires
Researchers have developed a new type of small-scale electric power generator able to produce alternating current through the cyclical stretching and releasing of zinc oxide wires encapsulated in a flexible plastic substrate with two ends bonded.
Just Scratching the Surface: New Technique Maps Nanomaterials as They Grow
Researchers at Rensselaer Polytechnic Institute have developed a measurement technique that will help scientists and companies map nanomaterials as they grow.
Denser computer chips possible with plasmonic lenses that 'fly'
Engineers at the University of California, Berkeley, are reporting a new way of creating computer chips that could revitalize optical lithography, a patterning technique that dominates modern integrated circuits manufacturing.
McMaster University unveils world's most advanced microscope
The most advanced and powerful electron microscope on the planet-capable of unprecedented resolution-has been installed in the new Canadian Centre for Electron Microscopy at McMaster University.
New research field promises radical advances in optical technologies
A new research field called transformation optics may usher in a host of radical advances including a cloak of invisibility and ultra-powerful microscopes and computers by harnessing nanotechnology and "metamaterials."
More Nanotechnology Current Events and Nanotechnology News Articles
 | Nanotechnology For Dummies (For Dummies (Math & Science)) by Richard D. Booker, Earl Boysen This title demystifies the topic for investors, business executives, and anyone interested in how molecule-sized machines and processes can transform our lives. Along with dispelling common myths, it covers nanotechnology's origins, how it will affect various industries, and the limitations it can overcome. This handy book also presents numerous applications such as scratch-proof glass, corrosion... |
 | Understanding Nanotechnology by Scientific American, editors at Scientific American Everyone today knows what technology is, but what is nanotechnology? Taken from the Greek, nano means 'one billionth part of' a whole. In modern parlance, it means very, very small. Nano-tech is the next step after miniaturization. Mobile phones are miniaturized versions of traditional landline phones. Watches are miniature clocks. Desktop computers are miniature versions of the original analogue... |
 | Nanotechnology: Science, Innovation, and Opportunity by Lynn E. Foster Inside the Emerging Multibillion-Dollar Nanotechnology Industry Suddenly, nanotechnology isn't science fiction or mere theory: It's becoming one of the world's fastest-growing, highest-impact industries. In Nanotechnology: Science, Innovation, and Opportunity, the field's leading experts offer an up-to-the-minute briefing on where the industry stands now, how it will unfold over the coming... |
 | Nanotechnology: A Gentle Introduction to the Next Big Idea by Mark A. Ratner, Daniel Ratner This book is the technical and business overview of tomorrow's scientific breakthrough. The authors survey the scientific research and business aspects of the field, try to explain the key concepts, provide a look at current developments, and give some thoughts on where nanotechnology is likely to go in the next few years. The book will be approachable and witty, with lots of illustrations and... |
 | Nanotechnology Demystified by Linda Williams, Wade Adams Get up to speed on nanotechnology and the many biological, chemical, physical, environmental, and political aspects of this developing... |
 | Soft Machines: Nanotechnology and Life by Richard A. L. Jones Enthusiasts look forward to a time when tiny machines reassemble matter and process information with unparalleled power and precision. But is their vision realistic? Where is the science heading? As nanotechnology (a new technology that many believe will transform society in the next on hundred years) rises higher in the news agenda and popular consciousness, there is a real need for a book which... |
 | Nanotechnology: Health and Environmental Risks (Perspectives in Nanotechnology) by Jo Anne Shatkin Interested in Nanotechnology but Can’t Bear to Wade through Detailed Technical Reports? While reports on nanotechnology by research and marketing firms as well as governmental agencies are comprehensive and insightful, they can often be tedious to read, expensive to procure, and generally unknown to nonexperts interested in this technology. Offering a reader-friendly and affordable alternative... |
 | Engines of Creation: The Coming Era of Nanotechnology by Eric Drexler This brilliant work heralds the new age of nanotechnology, which will give us thorough and inexpensive control of the structure of matter. Drexler examines the enormous implications of these developments for medicine, the economy, and the environment, and makes astounding yet well-founded projections for the... |
 | Nanofuture: What's Next For Nanotechnology by J. Storrs Hall Flying cars, space travel for everyone, the elimination of poverty and hunger, and powerful new tools to combat disease, and even ageing - these are some of the amazing predicted developments of nanotechnology, the coming science of designing and building machines at the molecular and atomic levels. Will this new scientific revolution be for better or worse? Some commentators have described... |
 | Nanotechnology: Basic Science and Emerging Technologies by Mick Wilson, Kamali Kannangara, Geoff Smith, Michelle Simmons, Burkhard Raguse The emergence of nanoscience portends a revolution in technology that will soon impact virtually every facet of our technological lives. Yet there is little understanding of what it is among the educated public and often among scientists and engineers in other disciplines. Furthermore, despite the emergence of undergraduate courses on the subject, no basic textbooks exist.Nanotechnology: Basic... |
| © 2008 BrightSurf.com |